Current Status and Sustainable Development Strategies of Traditional Korean Medicine Official Development Assistance (ODA) in Global Health

Article information

J Korean Med. 2024;45(1):255-268
Publication date (electronic) : 2024 March 1
doi : https://doi.org/10.13048/jkm.24019
1School of Korean Medicine, Pusan National University
2National Institute for Korean Medicine Development
3Korean Medicine Service Team Abroad
Correspondence to: Han Chae, School of Korean Medicine, Pusan National University, 49, Busandaehak-ro, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do, 50610, South Korea, Tel: +82-51-510-8470, Email: han@chaelab.org
Received 2024 January 19; Revised 2024 February 9; Accepted 2024 February 16.

Abstract

Objectives

Korea has a unique history of being both a recipient and a donor of Official Development Assistance (ODA), and the international community expects Korea to contribute to the development of developing countries by utilizing this experience. Traditional Korean medicine (TKM) seeks to contribute to global health, however the concept of ODA has been unclear and there has been no clear strategy and sustainable initiatives.

Methods

This study examines the concept of ODA and its application in global health, including business objectives, scale, evaluation principles, and development strategies. Additionally, we reviewed the current status of Traditional Korean medicine globalization projects and conducted a SWOT analysis of the internal and external environment of the TKM sector. Based on these findings, we redefined the concept of ODA for TKM and proposed suggestions for its development.

Results

The current study identified key ideas for TKM ODA. It should prioritize the improvement of primary healthcare in recipient countries, aligning with the international evaluation criteria of the SDGs. Secondly, TKM’s 70 years of experience can be leveraged to enhance both the competence and economic benefits of recipient countries’ medical systems. Based on these concepts, a TKM ODA development model was proposed, comprising two core visions, three development strategies and goals, and six core values.

Conclusion

This study systematically examined the TKM in global health and suggested sustainable development strategies for TKM ODA. Through its expansion, TKM could contribute to the advancement of global traditional medicine and its overall engagement in healthcare.

Fig. 1

The 17 Sustainable Development Goals of the United Nations

Fig. 2

Major targets of SDGs goal 3

Fig. 3

Development model of Traditional Korean Medicine ODA

Development Assistance Committee (DAC) List of Official Development Assistance (ODA) Recipients (Effective for Reporting on 2024 and 2025 Flows)

Official Development Assistance Amount of Korea (on a grant equivalent basis, USD million)

27 Core Partner Countries of Korea

SWOT Analysis of Traditional Korean Medicine

Acknowledgement

본 연구는 부산대학교의 연구비지원을 받았음.

(This work was supported by a 2-Year Research Grant of Pusan National University.)

References

1. OECD. Official development assistance (ODA) Accessed date 2024.1.10. Available from: https://www.oecd.org/dac/financing-sustainable-development/development-finance-standards/official-development-assistance.htm.
2. ODA Information Portal. Purposes and motivations of official development assistance (ODA) Accessed date 2024.1.10. Available from: https://www.oda.go.kr/opo/odin/mainInfoPage.do?P_SCRIN_ID=OPOA601000S02.
3. ODA Korea. Overview of international development cooperation Accessed date 2024.1.10. Available from: https://www.odakorea.go.kr/kor/cont/ContShow?cont_seq=34.
4. Kim S. J., Jeon H. E.. 2022;Categorization of Korean education ODA development plan: Focusing on previous researches. Journal of Education for International Understanding 17(3):129–162. https://doi.org/10.35179/jeiu.2022.17.3.129.
5. Jang J.-H.. 2020;Discovering the main issues and feedback loops underlying the education-related ODA projects. Korean Comparative Government Review 24(4):1–19. https://doi.org/10.18397/kcgr.2020.24.4.1.
6. Lee S.-W., Lee Y.. 2021;The international developmental cooperation and cultural official development assistance in South Korea. The Journal of Cultural Policy 35(1):191–225. https://doi.org/10.16937/jcp.2021.35.1.191.
7. Jo G., Jung Y.. 2019;A study on the implementation strategy of cultural ODA of Korea: Focused on Uzbekistan. Journal of International Area Studies 23(3):27–59. http://dx.doi.org/10.18327/jias.2019.7.23.3.27.
8. Joo J. H., Lee J. J.. 2021;Application of Saemaul education principles in the 1970’s to foster Saemaul ODA experts. Social Economy & Policy Studies 11(1):101–130. https://doi.org/10.22340/seps.2021.02.11.1.101.
9. Lee S.. 2021;An analysis of current situation about capacity building strategy for health sector in Korea’s official development assistance (ODA): An empirical study using qualitative research method. Journal of International Development Cooperation 16(1):33–57. http://doi.org/10.34225/jidc.2021.16.1.33.
10. Lee C.-E., Cha Y.-J.. 2023;Systematic review of research trends on South Korea’s SDGs. The Journal of Localitology (30):207–242. http://dx.doi.org/10.15299/tjl.2023.10.30.207.
11. Park Y. J., Seo D.. 2021;The development of evaluation criteria to enhance effectiveness of ODA projects. Journal of Regional Studies and Development 30(3):49–77. http://dx.doi.org/10.22739/ipaid.2021.30.3.49.
12. Yim H. R.. 2023;The impact of ODA to the economic development of recipient countries from the perspective of resource allocation. The Journal of Eurasian Studies 20(1):113–134. https://doi.org/10.31203/aepa.2023.20.1.006.
13. Lee J. R., Jung J. H., Kim J.-I., Lee H.. 2020;An analysis of ROK’s ODA researches and projects using text network analysis. Journal of International Development Cooperation 15(2):3–30.
14.

Act on the promotion of Korean medicine

15. Choi C-h. 2011;A study on the development of the Korean traditional medicine tourism industry. Northeast Asia Tourism Research 7(3):227–248.
16. Lee H.-J.. 2013;The globalization of East Asian traditional medicine and the change of medical hegemony. Society and Theory 22(5):377–398.
17. Yu T. G., Kim J. S.. 2015;Overseas entry-type research of the oriental medical institutions. Health Service Management Review 9(2):1–8.
18. Chae H.. 2010;Globalization of traditional Korean medicine: Development of traditional Korean medicine educational curriculum for foreign medical students. Journal of Physiology & Pathology in Korean Medicine 24(6):1068–1076.
19. Ministry of Health and Welfare & Kyung Hee University Research and Business Foundation. 2014;Establishment of comprehensive plan for ODA of traditional Korean medicine
20. Ministry of Health and Welfare & Joint Relevant Ministry. 2021;The 4th comprehensive plan for Korean medicine development 2021~2025
21. Chae H.. 2022;A study on the role of traditional Korean medicine in Korean-style international healthcare ODA policy.
22. Ministry of Health and Welfare. 2023. The ministry of health and welfare discusses strategies to revitalize the Korean traditional medicine industry and official development assistance 2023. 7. 10. Accessed date 2024.1.10. Available from: https://www.mohw.go.kr/gallery.es?mid=a10607030000&bid=0003&tag=&act=view&list_no=378871.
23. OECD. 2021;Official development assistance (ODA)
24. OECD. Official development assistance – definition and coverage Accessed date 2024.1.10. Available from: https://www.oecd.org/dac/financing-sustainable-development/development-finance-standards/officialdevelopmentassistancedefinitionandcoverage.htm.
25. UN. 1970;UN general assembly resolution 2626 (xxv)
26. OECD. 2023;ODA levels in 2022 – preliminary data detailed summary note
27. OECD. 2019;Evaluation criteria: Adapted definitions and principles for use
28. OECD. 2019;Better criteria for better evaluation
29. UN. The sustainable development agenda Accessed date 2024.1.10. Available from: https://www.un.org/sustainabledevelopment/development-agenda/.
30. UN. 2022;The sustainable development goals report 2022
31. OECD. OECD development assistance committee (DAC) welcomes Korean membership Accessed date 2024.1.10. Available from: https://www.oecd.org/dac/oecddevelopmentassistancecommitteedacwelcomeskoreanmembership.htm.
32.

Framework act on international development cooperation

33. ODA Korea. The implementation mechanism of official development assistance (ODA) in Korea 2023. 11. 15. Accessed date 2024.1.10. Available from: https://www.odakorea.go.kr/kor/cont/ContShow?cont_seq=41.
34. Joint Relevant Ministry. 2021;The 3rd comprehensive basic plan for international development cooperation (ODA) 2021–2025
35. 2020;Enforcement decree of the framework act on international development cooperation
36. ODA Korea. Country partnership strategy(CPS) 2023. 12. 13. Accessed date 2024.1.10. Available from: https://www.odakorea.go.kr/kor/cont/ContShow?cont_seq=22.
37. KOICA. 2017;KOICA’s mid-term sectoral strategy 2016–2020
38. KOICA. 2021;KOICA’s mid-term sectoral strategy 2021–2025
39. KOICA. 2023;KOICA’s 2022 ODA performance statistics
40. Macinko J. A., Starfield B.. 2002;Annotated bibliography on equity in health, 1980–2001. International Journal for Equity in Health 1(1):1–20.
41. WHO. 2023;World health statistics 2023: Monitoring health for the SDGs, sustainable development goals
42. Nam E. W.. 2018;International health cooperation and challenges for official development assistance. Health Policy and Mangemnet 28(3):320–326. https://doi.org/10.4332/KJHPA.2018.28.3.320.
43. Lee M.-S.. 2018;Global health promotion efforts for achieving the UN 2030 agenda for sustainable development. Korean Journal of Health Education and Promotion 35(4):1–18. https://doi.org/10.14367/kjhep.2018.35.4.1.
44. OECD. 2022;List of CRS purpose codes and voluntary budget identifier codes
45. UN. 2023;The sustainable development goals report 2023: Special edition
46. OECD.Stat. Creditor reporting system (CRS) Accessed date 2024.1.10. Available from: https://stats.oecd.org/Index.aspx?DataSetCode=crs1.
47. Lee J., Song J., Yoo A.. 2020;Current state and implication of ODA in international society’s response to infectious disease
48. KOICA. The KOICA health mid-term strategy framework Accessed date 2024.1.10. Available from: https://www.koica.go.kr/koica_kr/907/subview.do.
49. KOFIH. Healthcare development cooperation in developing countries Accessed date 2024.1.10. Available from: https://www.kofih.org/projects/developing/.
50. KOFIH. 2023;2022 Project performance report
51. KOFIH. 2023;Revised project plan and budget proposal for 2023
52. Joint Relevant Ministry. 2023;The proposed 2024 comprehensive implementation plan for international development cooperation (based on request amount)
53. Joint Relevant Ministry. 2023;The 2023 comprehensive implementation plan for international development cooperation (draft) (confirmed amount basis)
54. Kim H-k, Kang S., Noh D., Lee H., Jun J., Kang S-w, et al. 2015;Ways to vitalize ODA for health and social protection Korea Institute for Health and Social Affairs;
55. Choo Y.. 2012;A smart power strategy for providing ODA (official development assistance): Focused on aids to health in Cambodia. The e-Business Studies 13(2):159–184.
56. Choo M.. 2021;The current state and challenges of Korea’s international healthcare ODA. medical news
57. Joo H-j. 2023;KOMSTA, pre-ODA training for overseas medical volunteers
58. KOMSTA. KOICA WFK-KOMSTA dispatching Korean traditional medical volunteer team Accessed date 2024.1.10. Available from: https://komsta.org/overseas.
59. Kim T-h. 2021;The association of Korean medicine-KOICA, cooperate to increase the role of global partnership Korean doctors
60. KOFIH. 2017;ODA project evaluation manual for practitioners
61. OECD. 2013;OECD development assistance peer reviews: Korea 2012
62. WHO. 2009;WHO drug information

Article information Continued

Fig. 1

The 17 Sustainable Development Goals of the United Nations

Fig. 2

Major targets of SDGs goal 3

Fig. 3

Development model of Traditional Korean Medicine ODA

Table 1

Development Assistance Committee (DAC) List of Official Development Assistance (ODA) Recipients (Effective for Reporting on 2024 and 2025 Flows)

Category of the recipients Countries
Least Developed Countries (LDCs) Afghanistan, Angola, Bangladesh, Benin, Burkina Faso, Burundi, Cambodia, Central African Republic, Chad, Comoros, Democratic Republic of the Congo, Djibouti, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Kiribati, Lao People’s Democratic Republic, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Myanmar, Nepal, Niger, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sudan, Tanzania, Timor-Leste, Togo, Tuvalu, Uganda, Yemen, Zambia
Low Income Countries which are not LDCs (per capita GNI <= $1,135 in 2022) Democratic People’s Republic of Korea, Syrian Arab Republic
Lower Middle Income Countries and territories which are not LDCs (per capita GNI $1,136 – $4,465 in 2022) Algeria, Bhutan, Bolivia, Cabo Verde, Cameroon, Congo, Côte d’Ivoire, Egypt, Eswatini, Ghana, Honduras, India, Iran, Jordan, Kenya, Kyrgyzstan, Lebanon, Micronesia, Mongolia, Morocco, Nicaragua, Nigeria, Pakistan, Papua New Guinea, Philippines, Samoa, Sri Lanka, Tajikistan, Tokelau, Tunisia, Ukraine, Uzbekistan, Vanuatu, Viet Nam, Zimbabwe
Upper Middle Income Countries and territories which are not LDCs (per capita GNI $4,466 – $13,845 in 2022) Albania, Argentina, Armenia, Azerbaijan, Belarus, Belize, Bosnia and Herzegovina, Botswana, Brazil, China (People’s Republic of), Colombia, Costa Rica, Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, Equatorial Guinea, Fiji, Gabon, Georgia, Grenada, Guatemala, Guyana, Indonesia, Iraq, Jamaica, Kazakhstan, Kosovo, Libya, Malaysia, Maldives, Marshall Islands, Mauritius, Mexico, Moldova, Montenegro, Montserrat, Namibia, Nauru, Niue, North Macedonia, Palau, Panama, Paraguay, Peru, Saint Helena, Saint Lucia, Saint Vincent and the Grenadines, Serbia, South Africa, Suriname, Thailand, Tonga, Türkiye, Turkmenistan, Venezuela, Wallis and Futuna, West Bank and Gaza Strip

Table 2

Official Development Assistance Amount of Korea (on a grant equivalent basis, USD million)

2018 2019 2020 2021 2022
Official Development Assistance (ODA) 2,355 2,463 2,250 2,873 2,786
ODA/GNI (%) 0.14 0.15 0.14 0.16 0.17
Bilateral ODA 1,731 1,857 1,751 2,168 2,189
Grants 1,128 1,171 1,155 1,384 1,498
Loans 603 686 597 784 691
Multilateral ODA 624 606 499 704 597

Table 3

27 Core Partner Countries of Korea

Core Partner Countries (’11–15) 2nd Core Partner Countries (’16–20) 3rd Core Partner Countries (’21–25)
Asia Vietnam, Indonesia, Cambodia, Philippines, Bangladesh, Mongolia, Lao PDR, Nepal, Sri Lanka, Pakistan, East Timor Vietnam, Indonesia, Cambodia, Philippines, Bangladesh, Mongolia, Lao PDR, Nepal, Sri Lanka, Pakistan, Myanmar Vietnam, Indonesia, Cambodia, Philippines, Bangladesh, Mongolia, Lao PDR, Nepal, Sri Lanka, Pakistan, Myanmar, India
Africa Ghana, Ethiopia, Mozambique, Rwanda, Uganda, Congo, Nigeria, Cameroon Ghana, Ethiopia, Mozambique, Rwanda, Uganda, Tanzania, Senegal Ghana, Ethiopia, Rwanda, Uganda, Tanzania, Senegal, Egypt
Middle east and CIS Uzbekistan, Azerbaijan Uzbekistan, Azerbaijan Uzbekistan, Kyrgyzstan, Ukraine, Tajikistan
Latin America Colombia, Peru, Bolivia, Paraguay Colombia, Peru, Bolivia, Paraguay Colombia, Peru, Bolivia, Paraguay
Oceania Solomon Islands
Total Number of Countries 26 24 27

Table 4

SWOT Analysis of Traditional Korean Medicine

Internal factors Strength(S) Weakness(W)


External factors 70 years of development and successful experience in Korean medicine
World-leading Korean medicine research capabilities
Highly developed traditional medical system
Lack of ODA experience (recipient country/donor country)
Lack of ODA planning and implementation experts
Lack of policy support and research from the government
Opportunity (O) South Korea as a role model for ODA
Growing interest in traditional medicine
Increased funding for international health ODA
S/O W/O

Present and utilize Korea’s successful development experience to recipient countries
Highlight Korean medicine as a strength of Korean-style international health projects
Prioritize real-world development projects centered on recipient countries
Planning of effective projects centered on recipient countries
Increased capacity of domestic experts
Development of Korean medicine ODA professionals
Development of a comprehensive Korean medicine ODA plan

Threat (T) Lack of trust in new models of international development cooperation
Capacity needed for long-term
Korean medicine ODA projects
Increased competition from China in the field of traditional medicine, requiring differentiation and specialization
S/T W/T

Expansion of Policy support for showcase projects and successful experiences
Policy support for Korean medicine ODA research
Strengthening the role of the Korean medicine ODA expert group
Hosting of regular forums and symposia and network building
Increased ODA role of Korean medicine specialized institutions
Expansion of research on traditional medicine in overseas cultures/countries
Establishment of a career ladder for Korean medicine ODA